电邮这篇文章 Occurence of nontoxic goiter in patients with mastopathy
- 作者: Goryushina O.G.1
-
隶属关系:
- D.O. Ott Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences
- 期: 卷 48, 编号 5S (1999)
- 页面: 70-70
- 栏目: Articles
- ##submission.dateSubmitted##: 16.02.2022
- ##submission.dateAccepted##: 16.02.2022
- ##submission.datePublished##: 15.12.1999
- URL: https://journals.eco-vector.com/jowd/article/view/100932
- DOI: https://doi.org/10.17816/JOWD100932
- ID: 100932
如何引用文章
全文:
详细
Objective: To reveal the occurrence of nontoxic goiter in patients with mastopathy.
全文:
Objective: To reveal the occurrence of nontoxic goiter in patients with mastopathy.
Method: 101 women with mastopathy (94 of them had diffuse and 7 - nodular goiter) at the age of 17-55 were examined. The diagnosis of mastopathy was based on palpation, ultrasound (on the 7th-7th day of menstrual cycle) and roentgenologic (on the 7th-10th day) findings. The thyroid size and structure were evaluated by palpation and echography. Clinical data, thyroid and thyrotrophic hormones blood levels indicated that all women were euthyroid.
Results: Thyroid hyperplasia was found in 75 women (74%); diffuse enlargement of the thyroid — in 30 (40%); diffuse nodular goiter — in 35 (48%); nodular goiter — in 9 (12%). Among 66 patients with diffuse nontoxic goiter and diffuse nodular goiter, I degree thyroid enlargement was seen in 28 (42%), II degree — in 23 (35%), III degree — in 15 (23%). These data considerably exceed the occurrence of nontoxic goiter in the Leningrad population (Shliakhtina L.G., 1967).
Conclusion: Frequent combination of fibrocystic mastopathy with nontoxic goiter suggests possible role of iodine deficiency in pathogenesis of fibrocystic mastopathy.
作者简介
O. Goryushina
D.O. Ott Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences
编辑信件的主要联系方式.
Email: info@eco-vector.com
俄罗斯联邦, St. Petersburg
参考
补充文件
